Boston Scientific (BSX) Misses Q3 EPS by 2c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $42.43 -5.84%
Financial Fact:
Intangible asset impairment charges: 7M
Today's EPS Names:
GFL, NHTC, SKHY, More
Financial Fact:
Intangible asset impairment charges: 7M
Today's EPS Names:
GFL, NHTC, SKHY, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.73, $0.02 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.12 billion.
GUIDANCE:
Boston Scientific sees Q4 2026 EPS of $0.77-$0.79, versus the consensus of $0.83.
Boston Scientific sees FY2026 EPS of $3.16-$3.18, versus the consensus of $3.24.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q4 EPS by 29c; offers guidance
- Cactus, Inc. (WHD) Tops Q3 EPS by 19c
- West Fraser Timber Co. Ltd. (WFG) Reports Q3 results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
